The fibrillation and aggregation of a-synuclein (AS), along with the conformational transition from random coil to b-sheet, are the critical steps in the development of Parkinson's disease (PD). It is acknowledged that iron accumulation in the brain may lead to the fibrillation of AS. However, (-)-epigallocatechin gallate (EGCG) can penetrate the blood-brain barrier, chelate metal ions, and inhibit the fibrillation of amyloid proteins. Therefore, EGCG is warranted to be investigated for its potential to cure amyloid-related diseases. In the present work, we sought to study the effects of EGCG on Fe(III)-induced fibrillation of AS on both molecular and cellular levels.
The abnormal self-assembling of amyloid proteins is a critical step in the development of neurodegenerative disease (Taschenberger et al. 2013; Vuono et al. 2015 ). Parkinson's disease (PD) is one of the most common neurodegenerative diseases and has not been effectively treated to date (Bastide et al. 2015) . The characteristics of PD are the apoptosis of dopaminergic neurons in the substantial nigra and the emergence of intraneuronal protein inclusions known as Lewy bodies in the cytoplasm of nigral neurons (Sung et al. 2012; Taschenberger et al. 2013) . Lewy bodies are the pathological hallmark in the brain of PD patients and related to the death of neurons. The principal ingredient of Lewy bodies involved in PD is insoluble fibrils of structurally modified a-synuclein (AS) (Spillantini et al. 1998) . The monomeric AS is a 140-amino unstructured pre-synaptic protein in the healthy human body. Substantial studies have suggested that the amyloid fibril formation of AS is a pivotal step in the progress of PD (Breydo et al. 2012; Alafuzoff and Parkkinen 2014) .
It has been reported that metal ions such as Zn(II), Cu(II), Al(III), and Fe(III) are accumulated in the cerebral tissue of patients suffering from neurodegenerative diseases (Kozlowski et al. 2012; Viles 2012; Becerril-Ortega et al. 2014; Dusek et al. 2015) . In vitro assays also confirm that such metal ions can promote the fibrillation of amyloid proteins . The iron level is 15 lM/g dry weight in the total parkinsonian substantia nigra, which is 31-35% higher than that in control tissue (Dexter et al. 1989) . Furthermore, studies have found that iron dyshomeostasis can induce the aggregation of AS, which leads to the neuron death in the development of PD (Hare et al. 2013; Mena et al. 2015) . Since Fe(III) is involved in the aggregation of AS, chelation of Fe(III) may be a feasible approach to relieving the neurotoxicity caused by the fibrillation and aggregation of amyloid proteins.
The polyphenols including catechins in green tea and their derivatives show antioxidant, antibiotic, and neuroprotective properties against neuron injury, neurocyte death, and hippocampal neuron damage induced by aggregation of bsheet amyloid proteins Weinreb et al. 2004; Bitu Pinto et al. 2015; Renaud et al. 2015) . (-)-Epigallocatechin gallate (EGCG) (Fig. 1) is the most bioactive polyphenolic compound among tea polyphenols, and able to cross the blood-brain barrier (Weinreb et al. 2009 ). The phenolic hydroxyl groups of EGCG enable the protein to maintain a soluble and non-toxic structure (Zhang et al. 2013) . Moreover, EGCG is an excellent chelator to Fe(III) (Perron and Brumaghim 2009) . Therefore, it is warranted to explore further the effects of EGCG on Fe(III)-induced AS misfolding.
In this work, at the molecular level, we investigated the effect of EGCG on Fe(III)-induced conformational transition, fibrillation, and aggregation of AS by thioflavin T (ThT) fluorescence spectroscopy, circular dichroism (CD) spectroscopy, 1 H nuclear magnetic resonance ( 1 H NMR), and transmission electron microscopy (TEM). At the cellular level, we evaluated the neuroprotective effect of EGCG on the wild-type AS transduced PC12 cells (AS-PC12 cells) by cell counting kit-8 (CCK-8) assay, and investigated the antioxidant effect of EGCG on the Fe(III)-induced reactive oxygen species (ROS) in the cells by 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) method.
Materials and methods

Materials
ThT, tris-hydroxymethyl amino-methane (Tris) and EGCG were purchased from Sigma and Aldrich, USA. Ferric chloride (FeCl 3 ) and hydrochloric acid (HCl) were purchased from Sinopharm, China. Dulbecco's modified Eagle's medium (DMEM), horse serum, fetal bovine serum, and penicillin/streptomycin antibiotics were purchased from Gibco, Grand Island, NY, USA. Ninetysix-well polystyrene plates and 96-well black flat plates were purchased from Corning, USA. No institutional approval was needed.
Expression and purification of AS protein AS gene (GenBank: CR457058.1) was amplified by PCR and cloned into pT7N10C6 prokaryotic expression vector. The pT7N10C6 vector was reconstructed from the commercialized pET15b vector (Novagen, Darmstadt, GRE) with N-terminal 10-histidine tag and TEV protease (Tobacco Etch Virus protease) cleavage site. The expression plasmid pT7N10C6-AS was then introduced into Escherichia coli BL21 (DE3) pLsyS, within which the recombinant AS protein was expressed using the auto-induction system at an initial temperature of 37°C (Studier 2005) . When bacterial culture reaches optical density of OD k=600 = 0.8, the temperature was decreased to 16°C, and the cells were cultured for additional 20 h. The cells were collected by centrifugation (6000 g, 4°C, 15 min) and the cell pellet was suspended in 50 mM trishydroxymethyl amino-methane hydrochloride buffer (Tris-HCl buffer, pH = 8.5) with 150 mM NaCl and 5% glycerol. Cells were then disrupted by sonication, followed by centrifugation (20 000 g, 4°C, 60 min). After centrifugation, the supernatants were loaded onto HisTrap HP column (GE Healthcare, Fairfield, CT, USA), and eluted with 50 mM Tris-HCl buffer, pH = 8.5, containing 150 mM NaCl, 5% glycerol, and 140 mM imidazole. Afterward, the His 10 tag of AS was removed by incubation with His-tagged TEV protease overnight and separated on a HisTrap HP column (to collect the fraction that did not bind to column). Finally, the purified protein was exchanged into 50 mM Tris-HCl buffer by ultrafiltration.
Preparation of AS solutions
The protein assay reagent of bicinchoninic acid was used to calibrate AS concentrations. All AS solutions were freshly prepared with 5 mM Tris-HCl (pH = 7.4), and the final concentration of AS solutions was 50 lM. Fe(III)/AS aqueous solutions were prepared with Fe(III) concentration of 0, 10, 20, 40, and 100 lM. AS/EGCG solutions were prepared with EGCG concentration of 0, 10, 20, 50, 100, and 200 lM. For AS/Fe(III)/EGCG samples, the Fe(III)/EGCG molar ratio was 0, 0.5, 1, and 2 with EGCG concentration fixed at 20 lM. Then, various concentrations of Fe(III) and EGCG solutions were mixed with 50 lM AS solution and incubated for given hours with a 300 rpm stirring rate at 37°C for analysis. 
ThT fluorescence assay
The conformational transition of AS from random coil to b-sheet was probed by ThT fluorescence using Synergy H1 fluorescence microplate reader (BioTek, Winooski, VT, USA). ThT solution (40 lM) was added to the AS-based samples, and the final concentration of AS solution was 50 lM at 37°C in 96-well black flat plates (Corning Inc., New York, NY, USA) for the real-time test. The fluorescence intensity was monitored at the emission wavelength of 485 nm when excited at 450 nm. The experiments were performed in dark environment for avoiding the ThT fluorescence quenched by the light.
CD spectroscopy
Jasco spectropolarimeter was utilized to record CD spectra of the AS-based samples. The reaction mixture (10 lL) was diluted with 140 lL phosphate buffer (20 mM, pH = 7.4) in a 1 mm pathlength quartz cell at the scanning range from 190 to 250 nm. The final CD spectra were calculated by subtracting the spectrum of a blank control group (20 mM phosphate buffer only).
TEM image
TEM technique was applied to observe the morphology of AS aggregates. TEM samples were prepared from the solutions used for the fluorescence measurements. Protein solution (5 lL ) was removed at the end of the kinetic runs and swiftly diluted to 25 lg/mL solutions with Tris buffer. Then, 20 lL of the diluted samples were blotted on a carbon-coated Formvar 300 mesh copper grid twice and then negatively stained with saturated 2% (w/v) uranyl acetate for 2 min. Excess stain was removed with deionized water and then air-dried. The images of protein aggregates were acquired by Tecnai G2 20 TWIN (FEI, Hillsboro, OR, USA).
H NMR spectroscopy
The binding sites of Fe(III), EGCG and their mixture in the conformational transition of AS were detected by 1 H NMR spectrum using AVANCE III HD 500 MHz spectrometer (Bruker, Karlsuhe, GRE). AS was dissolved in 20 mM Tris-HCl (pH = 7.4), and the final concentration of AS solutions was 50 lM. The concentrations of 40 lM Fe(III) and/or 20 lM EGCG solutions were mixed with 50 lM AS solution. Then, samples incubated shakily at 37°C for 24 h. D 2 O was added in the ratio of 90% H 2 O/10% D 2 O for 1 H NMR measurement at 25°C. 1 H NMR spectra were acquired using the water suppressed pulse sequence.
Cell viability analysis by CCK-8 method Cell viability assay was carried out according to the protocol of CCK-8 method. The essential component of CCK-8 is WST-8 (2H-tetrazolium, 5-(2,4-disulfophenyl)-3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl)-innersalt, and sodium salt in 1 : 1). The wild-type AS transduced-PC12 cell line (AS-PC12 cells) with over-expressed AS was purchased from Shanghai Institutes for Biological Sciences, CAS, CN. The AS-PC12 cells were cultured in DMEM containing 6.5% horse serum (HS), 3.5% fetal bovine serum (FBS), and 1% penicillin/streptomycin antibiotics in thermostatic-constant moisture incubator. Approximately, 5 9 10 3 cells were seeded in 96-well plates in 100 lL medium per well. Cells were cultured at 37°C for 24 h, and then the original medium was replaced with 100 lL fresh DMEM containing 1.5% HS, 0.5% FBS, 1% penicillin/streptomycin antibiotics and different concentrations of Fe(III) and EGCG. Then the cells were incubated for another 24 h. An equal volume of medium was added to the control sample (AS-PC12 cells only).
Each sample was replicated in five wells. After incubation, 10 lL CCK-8 was injected into each well, and incubated for one more hour at 37°C before analysis. The absorption at 450 nm was monitored by a BioTek microplate spectrophotometer and the cell viability was calculated by the ratio of the absorbance of Fe(III) or EGCG contained groups to that of the control group. The experiment was repeated three times.
Intracellular ROS analysis by DCFH-DA method
Approximately, 5 9 10 5 cells were plated in six-well plates in 2.5 mL medium per well. Cells were cultured at 37°C for 24 h, and then the original medium was replaced with 2.5 mL fresh DMEM containing 1.5% HS, 0.5% FBS, 1% penicillin/streptomycin antibiotics, and different concentrations of Fe(III), EGCG, and their mixture. The cells were incubated for another 24 h, and then with 10 lM DCFH-DA for 30 min. After incubation, cells were collected subsequently and washed with DMEM and phosphatebuffered saline, and the cellular fluorescence intensity was monitored by flow cytometer (Beckman Coulter, CA, USA). Each sample was acquired for 80 000 events, and replicated in three independent experiments.
Statistical analysis
All data are presented as mean values AE SEM. SPSS 19.0 (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis, and oneway ANOVA test was performed to analyze the statistical significance between two groups. A difference is considered to be statistically significant when the p value was less than 0.05.
Results
AS fibrillation kinetics treated by Fe(III), EGCG, and their mixture When binding to the hydrophobic b-sheet-rich fibrils, ThT fluorescence intensity at 485 nm rises significantly (Naiki et al. 1989) , thus, ThT fluorescence is widely used to evaluate the b-sheet level during the conformational change (Krebs et al. 2005; Biancalana and Koide 2010) . In the present work, all the ThT contained samples were incubated for 24 h to ensure AS proteins achieving the maximum conformational change. The fibrillation kinetics of AS shown in Fig. 2a was consistent with the previous research (Wood et al. 1999) , following a characteristic sigmoidal curve, which demonstrates that AS fibrillation is nucleationdependent. Figure 2a shows that the increase in the concentration of AS resulted in the reduction in the lag time and the increase in the rate constant for fibril growth. Here, we investigated EGCG effect on the fibrillation at AS concentration of 50 lM. However, the lag phase was shortened substantially when Fe(III) was added from 0 to 20 lM into 50 lM AS solution, and the ThT fluorescence intensity increased to the maximum higher than that of the AS sample without Fe(III) (Fig. 2b) , that indicates that Fe(III) induced the increase in the b-sheet content. However, the maximum ThT fluorescence intensity decreased when Fe(III) concentration was higher than 40 lM, which suggests that higher ionic intensity would suppress the growth of the ordered bsheet conformation, although the lag phase was still shortened. The lag phase was elongated when EGCG existed (Fig. 2c) . The ThT fluorescence intensity decreased sharply along with EGCG added from 0 to 200 lM (Fig. 2c ). These results demonstrate that EGCG inhibited the formation of bsheet conformers in a dose-dependent manner. Moreover, the effect of EGCG on Fe(III)-induced AS conformational transition was also explored. AS was firstly incubated with Fe(III) (0, 10, 20, and 40 lM) for up to 1 h to ensure sufficient interaction between each other, then 20 lM EGCG was added to the sample (Fig. 2d ). In comparison with AS or Fe(III)/AS samples, the ThT fluorescence intensities of Fe (III)/EGCG/AS samples were attenuated. However, the maximum intensity at the final plateau was still higher than that of AS protein incubated with 20 lM EGCG (Fig. 2d) . Experimental data show that Fe(III) played a vital role in the nucleation period and accelerated AS fibrillation, while EGCG inhibited this process.
AS secondary structure treated by Fe(III), EGCG, and their mixture CD spectroscopy is more sensitive than ThT fluorescence spectroscopy to detect the AS secondary structure in the nucleation period. As shown in ThT fluorescence experiment, the maximum ThT fluorescence intensity decreased when Fe(III) concentration was higher than 40 lM. Therefore, we selected 40 lM Fe(III) as an effective concentration. Khokhar et al. reported that EGCG coordinates with Fe(III) in the ratio of 1 : 2 with binding sites at B and D rings (Khokhar and Apenten 2003) . Hence, we chose the series samples of 50 lM AS (Fig. 3a) with 40 lM Fe(III) (Fig. 3b) , 20 lM EGCG (Fig. 3c) , and Fe(III)/EGCG mixture of 40 lM Fe(III) and 20 lM EGCG (Fig. 3d) for CD study. Highly unfolded AS was found in the initial status with a highly negative ellipticity at 197 nm (Fig. 3a , dark solid curve) (Ranjbar and Gill 2009; Wallace and Janes 2010) . As incubation time went on from 0 to 8 h, the negative ellipticity at 197 nm was reduced for AS (Fig. 3a) , indicating the decrease in random coil conformers. Moreover, with the addition of 40 lM Fe(III) (Fig. 3b) , the negative ellipticity at 197 nm was reduced swiftly, compared to that of AS alone, demonstrating that the b-sheet conformers were formed within 4 h shorter than that for AS without Fe(III). When 20 lM EGCG (Fig. 3c) and Fe (III)/EGCG mixture (Fig. 3d) were added to AS, the negative ellipticity at 197 nm was reduced, respectively, Furthermore, the intensity was far smaller than that without EGCG, indicating that the conformational transition of AS was inhibited by EGCG or Fe(III)/EGCG mixture in the nucleation period. The result was in accordance with the lag phase elongated shown in Fig. 2 .
Morphologies of AS aggregates
TEM is generally used to observe and prove the morphology of aggregates qualitatively (Wang et al. 2015; Sun et al. 2016) . TEM images in Fig. 4a-f characterized the morphologies of AS aggregates after 24 h incubation. Figure 4a shows the morphology of aggregates formed by 50 lM AS alone. Figure 4b shows the elongated and interlaced AS fibrils formed in the presence of 20 lM Fe(III), which possessed a high density of needle-like fibrils of~13 nm in diameter and~350 nm in length. When AS incubated with 40 lM Fe(III), the fibrils wrinkled as shown in Fig. 4c , with a width of~20 nm and a length of~180 nm. Apparently, 20 lM Fe(III) promoted the formation of AS fibrils more efficiently than 40 lM Fe(III). This observation was consistent with our ThT and CD results. It was noted that these fibers were closely associated with the neurotoxicity to cells. Figure 4d and e are TEM images of AS incubated for 24 h with 20 lM EGCG and 200 lM EGCG, respectively. Figure 4d shows the co-existence of both fibrils and amorphous aggregates. Such amorphous aggregates were non-toxic in the pathological pathways of neurodegenerative diseases. With the high concentration of EGCG, only amorphous aggregates were found (Fig. 4e) . The images show that EGCG restrained the formation of AS fibrils, consistent with the above spectroscopic results. Figure 4f shows the cross-linked fibrils and amorphous aggregates of AS incubated with the mixture of Fe(III) and EGCG, where the formation of fibrils was disrupted to some extent. These observations provided strong evidence that EGCG inhibited Fe(III)-induced AS fibrillation.
The binding sites of Fe(III), EGCG, and their mixture in the aggregation of AS 1 H NMR spectroscopy was performed to elucidate the interactions of AS, Fe(III), EGCG, and Fe(III)/EGCG mixture in detail on the molecular level (Fig. 5) . We firstly examined the effect of incubation on AS fibrillation to understand the abnormal aggregation of AS. As shown in Fig. 5 , the resonances of 8.05-8.40 ppm and 6.95 ppm were assigned to His, 7.05-7.23 ppm to Phe, 6.60-6.90 ppm to Tyr, 1.98 ppm to Ile, 1.15-1.45 ppm to Ala, respectively. The spectrum linewidth of AS incubated for 24 h was broadened significantly, compared with that without incubation especially for the aromatic region from 6.58 to 8.55 ppm (Fig. 5a ), which suggests that the aggregates of AS were formed during incubation. Besides, the peak of H b in Ile became sharper, and the peak of H b in Ala was split. And notably, peaks at 2.50 ppm and 0.80 ppm appeared after incubation. The results indicate that residues of Ala, Ile, Phe, His, and Tyr might be involved in the fibrillation of AS. To investigate the binding sites of EGCG which prevent the formation of AS abnormal aggregates, we recorded 1 H NMR spectrum of 50 lM AS in the presence of 20 lM EGCG after 24 h incubation. It was found that the line broadenings were suppressed when AS co-incubated with EGCG, which implies that EGCG significantly inhibited the abnormal aggregation of AS. As shown in Fig. 6 , when AS was co-incubated with EGCG, the peak of H b in Ile was somewhat broadened, compared with that of fresh AS, which suggests that the Ile was involved in the EGCG interaction with AS.
To investigate the binding sites of Fe(III) which accelerated the fibrillation of AS, we recorded 1 H NMR spectrum of 50 lM AS in the presence of 40 lM Fe(III) after 24 h incubation. The addition of Fe(III) broadened the resonances of the aromatic region, sharpened the peak of H b in Ile at 1.95 ppm, and split the peak of H b in Ala at 1.25 ppm. Importantly, the peak of 3,5-H of benzene in Tyr at 6.74 ppm was spilt, and the peak of H b in Ala became sharper than the (Fig. 5) , manifesting that EGCG impeded Fe(III)-induced AS fibrillation. Moreover, the resonances of EGCG at 2.60 ppm remarkably disappeared when EGCG co-existed with Fe(III), which suggests that EGCG interacted with Fe(III).
Effect of Fe(III), EGCG, and their mixture on the viability of AS-PC12 cells CCK-8 assay demonstrated that when AS-PC12 cells which over-express AS were incubated with Fe(III) for 48 h, the cell viability was reduced when compared with that of the control group (without Fe(III), Fig. 6a ). In contrast, when the cells were incubated with EGCG from 0 to 10 lM for 48 h, the cell viability was improved in a dose-dependent manner (Fig. 6b) . However, when EGCG concentration was higher than 25 lM, the cell viability was, in turn, reduced dramatically (Fig. 6b) . Interestingly, when the cells were incubated with 10 lM Fe(III) for 2 h prior to the addition of EGCG, the cell viability increased remarkably at the EGCG/ Fe(III) ratio from 0.5 to 1 (Fig. 6c) , and then decreased at the EGCG/Fe(III) ratio from 2 to 3 (Fig. 6c) . However, the cell viability was still higher than that without EGCG, demonstrating that EGCG prevented AS-PC12 cytotoxicity induced by Fe(III). We also measured the viability of PC12 cells treated with various concentration of Fe(III) (Fig. 6d) , EGCG (Fig. 6e) , and their mixture (Fig. 6f) for 24 h. The PC12 cell viability was not significantly changed, in contrast with that of the AS-PC12.
Effect of Fe(III), EGCG, and their mixture on the production of ROS in the AS-PC12 cells ROS in the cells was probed by an oxidation-sensitive agent of DCFH-DA which is easily oxidized to the highly fluorescent dichlorofluorscein (DCF), using a flow cytometer (Ex: 488 nm; Em: 525 nm). We illustrated in Fig. 7 that Fe (III) incubated with cells for 24 h dramatically increased ROS levels in a dose-response manner, whereas EGCG decreased ROS in a dose-dependent manner, compared with the control group. However, when cells were treated with the mixture of 5 lM Fe(III) and various concentration of EGCG, the intracellular ROS were obviously decreased, compared with the 5 lM Fe(III) group. Moreover, compared with the control group, ROS in groups treated with the mixture were apparently weakened. These results demonstrate that Fe(III) induced ROS in the AS-PC12 cells, displaying a significant oxidant capacity, and EGCG not only inhibited ROS production but also receded the Fe(III)-induced oxidation, showing a remarkable antioxidant ability.
Discussion
Effect of Fe(III) on AS fibrillation
The binding of Fe(III) with AS accelerated the amyloid formation of AS, as shown in the present work, which agrees well with previous studies (Uversky et al. 2001; Golts et al. 2002) . Bharathi and Rao (2007) titrated AS with Fe(III) using isothermal titration calorimetry, and found that stoichiometry of AS to Fe(III) was 1 : 1. Peng et al. (2010) also reported that the complex of AS and Fe(III) H NMR results, we found that Fe(III) interacted with amino acid sites of Tyr and Ala. We suppose that AS and Fe(III) form a complex by Fe(III) anchoring to Tyr and Ala residues, and bridging AS monomers, thus accelerate the fibrillation of AS. Some work previously reported that Tyr and Ala play a vital role in the fibrillation of AS. Freed et al. demonstrated that the mutation of Cys by Tyr accelerated the protein aggregation, leading to the cell death (Zhou and Freed 2004) . In addition, the mutations of A30P and A53T increased the rate of oligomerization and aggregation of AS (Li et al. 2002) . These results support our hypothesis based on NMR data that Tyr and Ala are crucial to the fibrillation of AS. It is well known that AS (pI = 4.7) is negatively charged in neutral solution. We speculate that in the presence of high concentration of Fe(III), the high ionic intensity would impose strong electrostatic repulsions between AS chains, which leads to the rapid formation of the amorphous aggregates.
Effect of EGCG on AS fibrillation
Many small natural polyphenols, such as resveratrol, curcumin, baicalein, etc. for the inhibition of amyloid formation of AS have been reported (Caruana et al. 2011; Gautam et al. 2017) to have anti-cancer and anti-oxidative capabilities. The vicinal poly-hydroxyphenyl OH groups in polyphenolic compounds play a vital role in inhibition of amyloids (Meng et al. 2009 ). Although curcumin can interact with the side chains of amino acid residues in AS via hydrogen bonding to bely the hydrophobic patches of the protein molecules (Ahmad and Lapidus 2012) , its instability and poor water-solubility limit the potential for a good drug candidate. Resveratrol contains a rotation-restricted aliphatic double bond and lacks the vicinal -OH groups, making it far less effective than curcumin and EGCG. EGCG is reported to directly bind to hydrophobic motifs in protein sequence through a strong p-p interaction of aromatic groups, and bind to hydrophilic motifs through hydrogen bonding of hydroxyl groups. These interactions inhibit fibrillation of many amyloidogenic proteins including a-synuclein, amyloid-b polypeptide, and islet amyloid polypeptide (Bieschke et al. 2010; Zhang et al. 2013; Pastore and Wei 2015) . Moreover, EGCG can efficiently remodel amyloid fibrils into unstructured, non-toxic oligomers (Bieschke et al. 2010) . The gallate ester moiety and the phenolic hydroxyls in B and D rings in EGCG serve as the key sites to form hydrogen bonds (Zhang et al. 2013) . In this study, we speculate that the effect factors of EGCG on AS conformation include: (i) the p-p stacking between the aromatic rings in EGCG and aromatic residues in AS, (ii) the hydrogen bonding between the phenolic hydroxyls in EGCG and hydrophilic residues in AS. These factors inhibit the formation of the ordered AS fibrils but are favorable to the formation of amorphous aggregates.
Interaction of EGCG with Fe(III)
EGCG is an ideal chelator for metal ions because of its active phenolic hydroxyls. It was reported that EGCG reacts with Fe(III) to form a 2 : 1 metal/ligand complex through hydroxyls in B and D rings (Ryan and Hynes 2007 Effect of EGCG on the Fe(III)-induced AS-PC12 cell death As shown in Fig. 6 , EGCG significantly attenuated AS-PC12 cell death induced by Fe(III). There are two possible mechanisms for EGCG protecting cells. One is anti-oxidative stress; the other is reducing the Fe(III)-induced AS overexpression and b-sheet fibrillation. Oxidative stress is fatal to cell survival and proliferation, and Fe(III) is one of the vital factors to oxidative stress. EGCG can coordinate Fe(III), and thus reducing the Fe(III)-induced oxidative stress in the cells (Fig. 7) . The homeostasis of Fe is regulated at the translational level by iron regulatory protein (Andersen 2004) . Rogers et al. have reported that iron responsive element in the 5 0 -untranslated region (5 0 UTR) of the AS transcript is playing a potential role in the aggregation of AS (Friedlich et al. 2007; Olivares et al. 2009 ). Fe(III) might regulate AS aggregation through the iron responsive element/iron regulatory protein system, and EGCG, a Fe(III) chelator, acts as a translation inhibitor of AS transcripts. We observed in the experiments that once Fe(III) was trapped by EGCG, the cells grew and proliferated much healthier than cells without EGCG. Besides, AS b-sheet oligomers were reported to induce reactive oxygen species, which are cytotoxic to PC12 cells (Tabner et al. 2005) . EGCG can reduce the Fe(III)-induced AS b-sheet fibrillation and ROS in AS-PC12 cells. Fe(III) induced ROS in the AS-transduced cells, while EGCG not only inhibited ROS production but also receded the Fe(III)-induced oxidation in the cells, showing a remarkable antioxidant ability, which is consistent with the analysis of cells viability. However, excessive EGCG is harmful to cell proliferation. We postulate that high concentration of EGCG may exceed the maximum tolerated dose in cells, which may lead to the cell death. Therefore, it is crucial to use proper concentration of EGCG in preventing cell damage.
Conclusion
This study revealed that EGCG could inhibit the Fe(III)-induced AS fibrillation and aggregation by suppressing the conformational transition of AS from random coil to b-sheet, and attenuate the Fe(III)-induced AS-PC12 cell death. These findings may help us to better understanding the pathological process of neurodegenerative diseases, and prove that EGCG possesses extraordinary biological properties for the treatment of neurodegenerative diseases.
